Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of SFPP in Osteoarthritis
jRCT2080221798Phase 3
- Sponsor
- Taisho Pharmaceutical
- Start
- May 2012
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in osteoarthritis (OA), sponsored by Taisho Pharmaceutical.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080221798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221798.